Mirati Therapeutics, Inc.

RHUMBLINE ADVISERS

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/8/2024

Shares

61,220

Value ($000)

3,597

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/8/2024	3,597	0.0%	61,220	12/31/2023
2023 Q3	11/9/2023	2,259	0.0%	51,871	9/30/2023
2023 Q2	8/8/2023	1,859	0.0%	51,447	6/30/2023
2023 Q1	5/11/2023	1,801	0.0%	48,437	3/31/2023
2022 Q4	2/14/2023	2,232	0.0%	49,254	12/31/2022
2022 Q3	11/10/2022	3,224	0.0%	46,163	9/30/2022
2022 Q2	8/11/2022	2,628	0.0%	39,142	6/30/2022
2022 Q1	5/12/2022	2,922	0.0%	35,534	3/31/2022
2021 Q4	2/10/2022	5,641	0.0%	38,455	12/31/2021
2021 Q3	11/12/2021	6,418	0.0%	36,277	9/30/2021
2021 Q2	8/5/2021	6,010	0.0%	37,209	6/30/2021
2021 Q1	5/6/2021	8,418	0.0%	49,143	3/31/2021
2020 Q4	2/10/2021	11,815	0.0%	53,793	12/31/2020
2020 Q3	11/12/2020	7,817	0.0%	47,078	9/30/2020
2020 Q2	8/13/2020	6,471	0.0%	56,675	6/30/2020
2020 Q1	5/6/2020	3,173	0.0%	41,277	3/31/2020
2019 Q4	2/5/2020	4,893	0.0%	37,970	12/31/2019